BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 35123603)

  • 1. [The Expression and Function of NK Cells in Patients with Acute Myeloid Leukemia].
    Liu L; Chen X; Jin HM; Zhao SS; Zhu Y; Qian SX; Wu YJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Feb; 30(1):49-55. PubMed ID: 35123603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Percentages and functions of natural killer cell subsets in peripheral blood of patients with severe aplastic anemia].
    Li ZS; Shao ZH; Fu R; Wang J; Li LJ; Zhang T; Wang HQ; Wu YH; Ruan EB; Song J; Qu W; Liu H; Xing LM; Wang XM; Liang Y; Guan J; Wang GJ
    Zhonghua Yi Xue Za Zhi; 2011 Apr; 91(16):1084-7. PubMed ID: 21609587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of CD158 and NKG2A Inhibitory Receptors and Underexpression of NKG2D and NKp46 Activating Receptors on NK Cells in Acute Myeloid Leukemia.
    Sandoval-Borrego D; Moreno-Lafont MC; Vazquez-Sanchez EA; Gutierrez-Hoya A; López-Santiago R; Montiel-Cervantes LA; Ramírez-Saldaña M; Vela-Ojeda J
    Arch Med Res; 2016 Jan; 47(1):55-64. PubMed ID: 26876298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression of Costimulatory Molecule Tim3 on NK Cells and Its Subsets in Patients with Acute Myeloid Leukemia].
    Wu WH; Shao JW; Jiang YL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Dec; 28(6):1899-1903. PubMed ID: 33283717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased expression of NKG2D, NKp46, DNAM-1 receptors, and intracellular perforin and STAT-1 effector molecules in NK cells and their dim and bright subsets in metastatic melanoma patients.
    Mirjačić Martinović KM; Babović NLj; Džodić RR; Jurišić VB; Tanić NT; Konjević GM
    Melanoma Res; 2014 Aug; 24(4):295-304. PubMed ID: 24769842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased Peripheral NKG2A-NKG2D+CD3-CD16+CD56dim NK Cell Subset Was Positively Correlated with Antiphospholipid Antibodies in Patients of Obstetric Antiphospholipid Syndrome.
    Zhang Y; Zhao Y; Si W; Yang B; Lin M; Zheng J; Cui L
    Immunol Invest; 2022 Feb; 51(2):425-437. PubMed ID: 33103514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early Cytomegalovirus Reactivation and Expansion of CD56
    Jang JE; Hwang DY; Chung H; Kim SJ; Eom JI; Jeung HK; Song J; Kim JS; Cheong JW; Min YH
    Biol Blood Marrow Transplant; 2019 Oct; 25(10):2070-2078. PubMed ID: 31212079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dimensional mass cytometry analysis of NK cell alterations in AML identifies a subgroup with adverse clinical outcome.
    Chretien AS; Devillier R; Granjeaud S; Cordier C; Demerle C; Salem N; Wlosik J; Orlanducci F; Gorvel L; Fattori S; Hospital MA; Pakradouni J; Gregori E; Paul M; Rochigneux P; Pagliardini T; Morey M; Fauriat C; Dulphy N; Toubert A; Luche H; Malissen M; Blaise D; Nunès JA; Vey N; Olive D
    Proc Natl Acad Sci U S A; 2021 Jun; 118(22):. PubMed ID: 34050021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human natural killer cell maturation defect supports in vivo CD56(bright) to CD56(dim) lineage development.
    Domaica CI; Fuertes MB; Uriarte I; Girart MV; Sardañons J; Comas DI; Di Giovanni D; Gaillard MI; Bezrodnik L; Zwirner NW
    PLoS One; 2012; 7(12):e51677. PubMed ID: 23240056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural killer cell subsets and receptor expression in peripheral blood mononuclear cells of a healthy Korean population: Reference range, influence of age and sex, and correlation between NK cell receptors and cytotoxicity.
    Phan MT; Chun S; Kim SH; Ali AK; Lee SH; Kim S; Kim SH; Cho D
    Hum Immunol; 2017 Feb; 78(2):103-112. PubMed ID: 27884732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired circulating CD56
    Jiang Y; Chen Y; Chen L; Yao W; Guan J; Liu X; Wei X; Lin X
    Hum Immunol; 2020 Jan; 81(1):32-40. PubMed ID: 31735440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural Killer Cells Generated From Human Induced Pluripotent Stem Cells Mature to CD56
    Euchner J; Sprissler J; Cathomen T; Fürst D; Schrezenmeier H; Debatin KM; Schwarz K; Felgentreff K
    Front Immunol; 2021; 12():640672. PubMed ID: 34017328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Quantities and function of NK cells in patients with immune thrombocytopenia].
    Zhang YJ; Qu W; Liu H; Wang YH; Liu CY; Li LJ; Wang HQ; Fu R; Xing LM; Shao ZH
    Zhonghua Yi Xue Za Zhi; 2017 Apr; 97(16):1231-1235. PubMed ID: 28441851
    [No Abstract]   [Full Text] [Related]  

  • 14. [Interferon-α mediating the functional damage of CD56
    Zhao XG; Liu JQ; Huang HN; Lu ZM; Bai ZR; Li X; Qi JJ
    Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Dec; 55(6):975-981. PubMed ID: 38101777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A CD8α(-) subpopulation of macaque circulatory natural killer cells can mediate both antibody-dependent and antibody-independent cytotoxic activities.
    Vargas-Inchaustegui DA; Demberg T; Robert-Guroff M
    Immunology; 2011 Nov; 134(3):326-40. PubMed ID: 21978002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor infiltrating NK cell (TINK) subsets and functional molecules in patients with breast cancer.
    Rezaeifard S; Talei A; Shariat M; Erfani N
    Mol Immunol; 2021 Aug; 136():161-167. PubMed ID: 34171565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NK cells and the profile of inflammatory cytokines in the peripheral blood of patients with advanced carcinomas.
    Saito LM; Ortiz RC; Amôr NG; Lopes NM; Buzo RF; Garlet GP; Rodini CO
    Cytokine; 2024 Feb; 174():156455. PubMed ID: 38043142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression of Tim-3 on natural killer cells in patients with acute myeloid leukemia and its clinical significance].
    Ma JF; Li CX; Wu DP; Sun ZL; Yan CL
    Zhonghua Xue Ye Xue Za Zhi; 2019 Sep; 40(9):755-758. PubMed ID: 31648478
    [No Abstract]   [Full Text] [Related]  

  • 19. Optimization of Human NK Cell Manufacturing: Fully Automated Separation, Improved Ex Vivo Expansion Using IL-21 with Autologous Feeder Cells, and Generation of Anti-CD123-CAR-Expressing Effector Cells.
    Klöß S; Oberschmidt O; Morgan M; Dahlke J; Arseniev L; Huppert V; Granzin M; Gardlowski T; Matthies N; Soltenborn S; Schambach A; Koehl U
    Hum Gene Ther; 2017 Oct; 28(10):897-913. PubMed ID: 28810809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Changes of natural kill cell in peripheral blood of patients with myelodysplastic syndrome].
    Mi H; Fu R; Wang H; Qu W; Ruan E; Wang X; Wang G; Liu H; Wu Y; Song J; Xing L; Guan J; Li L; Jiang H; Zhang W; Yue L; Shao Z
    Zhonghua Yi Xue Za Zhi; 2014 Mar; 94(10):737-41. PubMed ID: 24844955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.